Context Therapeutics Inc. - Common Stock (CNTX)

CUSIP: 21077P108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
91,837,471
Total 13F shares
65,197,080
Share change
-3,770,886
Total reported value
$95,840,638
Price per share
$1.47
Number of holders
42
Value change
-$5,288,639
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 21077P108?
CUSIP 21077P108 identifies CNTX - Context Therapeutics Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q4 2025

As of 31 Dec 2025, Context Therapeutics Inc. - Common Stock (CNTX) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 65,197,080 shares. The largest 10 holders included MPM BIOIMPACT LLC, Blue Owl Capital Holdings LP, Deep Track Capital, LP, Nextech Invest, Ltd., Avidity Partners Management LP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and MARSHALL WACE, LLP. This page lists 42 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.